Validation of Serum MicroRNAs-19a, -24, and -29a as Potential Markers to Differentiate Pancreatic Cancer-Associated Diabetes From Type 2 Diabetes Mellitus

Pancreas. 2022 May 1;51(5):e76-e77. doi: 10.1097/MPA.0000000000002040.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / diagnosis
  • Diabetes Mellitus, Type 2* / genetics
  • Humans
  • MicroRNAs* / genetics
  • Pancreatic Neoplasms* / diagnosis
  • Pancreatic Neoplasms* / genetics

Substances

  • MicroRNAs